US Senate panel chief seeks $300 bill for Rx

5 August 2001

Senator Max Baucus, the new chairman of the Senate Finance Committee,has said that the $300 billion which Congress agreed in May should be set aside to extend Medicare prescription drug coverage over the next 10 years (Marketletters passim) should be used purely for the provision of a prescription drug benefit.

Sen Baucus also rejected proposals for a $52 monthly premium for enrollment in the plan as being too high. He told the Associated Press that "we know we have to get the premium down, otherwise people won't buy in."

The Committee chairman emphasized the importance of getting agreement on a prescription drug benefit by the end of this year, warning that if this is not accomplished, "there's no guarantee we'll have $300 billion next year with the budget squeezes."

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight